Sharon Townson
Chief Scientific Officer at Monte Rosa Therapeutics, Inc. (GLUE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $424K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 7SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 5,60068,245 held (−8%) | $23.25 | $130K | -55.7% |
| Jul 7SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 40067,845 held (−1%) | $24.13 | $10K | -57.3% |
| Jun 25SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 3,00067,845 held (−4%) | $20.00 | $60K | -48.5% |
| Jun 18SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 3,00067,845 held (−4%) | $19.00 | $57K | -45.8% |
| Jun 1SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell Plan | 6,00067,845 held (−8%) | $19.87 | $119K | -48.2% |
| Jan 5SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell | 3,15567,845 held (−4%) | $15.17 | $48K | -32.1% |
- Sell
Chief Scientific Officer Sharon Townson sold $130K of GLUE at $23.25 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Sharon Townson sold $10K of GLUE at $24.13 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Sharon Townson sold $60K of GLUE at $20.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Sharon Townson sold $57K of GLUE at $19.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Sharon Townson sold $119K of GLUE at $19.87 — pre-scheduled 10b5-1 plan sale.